158 related articles for article (PubMed ID: 26548471)
1. [Sunitinib and zoledronic acid induced osteonecrosis of the jaw].
Soós B; Vajta L; Szalma J
Orv Hetil; 2015 Nov; 156(46):1865-70. PubMed ID: 26548471
[TBL] [Abstract][Full Text] [Related]
2. Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
Bozas G; Roy A; Ramasamy V; Maraveyas A
Onkologie; 2010; 33(6):321-3. PubMed ID: 20523097
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?
Ayllon J; Launay-Vacher V; Medioni J; Cros C; Spano JP; Oudard S
Ann Oncol; 2009 Mar; 20(3):600-1. PubMed ID: 19188135
[No Abstract] [Full Text] [Related]
4. Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases.
Lee JJ; Cheng SJ; Wang YP; Jeng JH; Chiang CP; Kok SH
Head Neck; 2013 Jan; 35(1):E6-10. PubMed ID: 21523843
[TBL] [Abstract][Full Text] [Related]
5. [Osteonecrosis of the jaw developing during bisphosphonate treatment].
Udvardy E; Redl P; Márton I
Magy Onkol; 2008 Mar; 52(1):81-7. PubMed ID: 18403302
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.
Wynn RL
Gen Dent; 2011; 59(5):330-2. PubMed ID: 22313815
[No Abstract] [Full Text] [Related]
7. Avascular osteonecrosis of the mandible following bisphosphonate therapy.
Chandra PA; Chandra AB; Todd GK
Am J Ther; 2009; 16(1):65-7. PubMed ID: 22573056
[TBL] [Abstract][Full Text] [Related]
8. Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases.
Hoefert S; Eufinger H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):463-9. PubMed ID: 20692189
[TBL] [Abstract][Full Text] [Related]
9. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
[TBL] [Abstract][Full Text] [Related]
11. The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw.
Wilde F; Heufelder M; Winter K; Hendricks J; Frerich B; Schramm A; Hemprich A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Feb; 111(2):153-63. PubMed ID: 20674411
[TBL] [Abstract][Full Text] [Related]
12. Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.
Edwards BJ; Gounder M; McKoy JM; Boyd I; Farrugia M; Migliorati C; Marx R; Ruggiero S; Dimopoulos M; Raisch DW; Singhal S; Carson K; Obadina E; Trifilio S; West D; Mehta J; Bennett CL
Lancet Oncol; 2008 Dec; 9(12):1166-72. PubMed ID: 19038763
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.
Ficarra G; Beninati F
Head Neck Pathol; 2007 Dec; 1(2):132-40. PubMed ID: 20614264
[TBL] [Abstract][Full Text] [Related]
14. [Bisphosphonate-induced jaw osteonecrosis--prevention and treatment].
; ; ; ;
Orv Hetil; 2010 Jan; 151(4):148-9. PubMed ID: 20071321
[No Abstract] [Full Text] [Related]
15. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.
Migliorati CA; Siegel MA; Elting LS
Lancet Oncol; 2006 Jun; 7(6):508-14. PubMed ID: 16750501
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid.
Cetiner S; Sucak GT; Kahraman SA; Aki SZ; Kocakahyaoglu B; Gultekin SE; Cetiner M; Haznedar R
J Bone Miner Metab; 2009; 27(4):435-43. PubMed ID: 19240969
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
Estilo CL; Van Poznak CH; Wiliams T; Bohle GC; Lwin PT; Zhou Q; Riedel ER; Carlson DL; Schoder H; Farooki A; Fornier M; Halpern JL; Tunick SJ; Huryn JM
Oncologist; 2008 Aug; 13(8):911-20. PubMed ID: 18695259
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate-related osteonecrosis of the jaws--a case report.
Kamoh AK; Ogle O
Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
[TBL] [Abstract][Full Text] [Related]
19. Histopathological features of osteonecrosis of the jaw associated with bisphosphonates.
Paparella ML; Brandizzi D; Santini-Araujo E; Cabrini RL
Histopathology; 2012 Feb; 60(3):514-6. PubMed ID: 22168273
[No Abstract] [Full Text] [Related]
20. Avascular necrosis of the proximal carpal row of the wrist. A possible complication of bisphosphonate administration.
Didden K; De Smet L; Vandenberghe L; Sciot R; Degreef I
Chir Main; 2012 Dec; 31(6):355-7. PubMed ID: 23177907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
